BRITS are being urged to look out for symptoms of RSV after an increase in cases of the highly contagious disease. The virus ...
Two new studies suggest that nirsevimab (Beyfortus) is 80% to 89% effective in protecting infants from poor respiratory ...
Respiratory Syncytial Virus (RSV) is a common virus in babies and often starts with mild cold-like symptoms. For some infants ...
The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.
Providing year-round access to RSV immunization would minimize the risk of large seasonal outbreaks across the nation, ...
A pooled multicountry analysis shows that immunisation with nirsevimab effectively reduced RSV-related hospitalisation in ...
IT’S that time of year where everyone seems to have caught some sort of bug – so it’s no surprise if your tot has got a cough ...
Providing year-round access to RSV immunization would minimize the risk of large seasonal outbreaks across the nation, ...
After a Type C discussion, Blue Lake got the FDA nod to enrol both RSV-positive and negative children above the age of 18 ...
Background Respiratory syncytial virus (RSV) is an important cause of acute lower respiratory infections (ALRI) among under-5 ...